Advances two in vivo-engineered TCR-T candidates for solid tumors to IND-enabling studies with plans to initiate Phase 1 development in Q4 ...

TScan Therapeutics advances solid tumor TCR-T candidates to studies, pauses heme malignancies trial, and reduces workforce by ...

Kazia Therapeutics (KZIA) said Tuesday that data showed its paxalisib therapy significantly reduced tumor burden and the total amount of cancer in the body by 52% in a preclinical model of ...

Kazia Therapeutics (KZIA) said Tuesday that it will expand its ongoing paxalisib clinical trial into hormone receptor-positive, HER2-negative advanced breast cancer after preclinical data showed ...

Paxalisib Monotherapy Significantly Reduced Tumor Burden in Pre-Clinical Model of MSS/pMMR Colorectal Cancer, With the Addition of Pembrolizumab Driving a ...

Preclinical Data Show Paxalisib Combined With Standard-of-Care Therapy Is Well Tolerated and Produces Statistically Significant Antitumor Activity ...

Juniper Biosciences today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to JBS-003 (18F-fluoromisonidazole, or FMISO), the first-in-class ...

ORR observed among 76 evaluable patients in the ovarian cancer cohort with a median duration of response of 10.0 monthsRecent FDA interaction ...

Tumor treating fields have demonstrated efficacy and safety, especially in glioblastoma treatment, but clinical uptake ...

Ed Sheeran was already facing one of the most frightening periods of his life when doctors discovered a tumor in his pregnant ...

Women who used the Depo-Provera birth control shot and were later diagnosed with a meningioma brain tumor rarely follow the ...

For a decade, Christine Coleman and Peter Perales have been using their time off from work to pursue their hobby of nomadic ...